Cancer Drugs
Zejula
Also known as: Niraparib, PARP inhibitor
Definition
Niraparib, a PARP inhibitor used as maintenance therapy in ovarian cancer regardless of BRCA status.
Detailed Explanation
Zejula maintenance after platinum response prolongs progression-free survival in ovarian cancer, including HRD-negative patients, with once-daily oral dosing.